Výsledky vyhledávání - "Tomokazu, Ishitobi"

Hemobilia after laparoscopic cholecystectomy that was successfully treated conservatively: Case report

Autor: Yasushi Miyata, Tomokazu Ishitobi, Shinya Kodama, Senichiro Yanagawa, Ryosuke Arata, Kazuo Sumimoto

Publikováno v: International Journal of Surgery Case Reports

Highlights • Hemobilia from pseudoaneurysm rupture after laparoscopic cholecystectomy is rare. • Due to consequent rapid hemodynamic instability, it could be life threatening. • Non-contrast CT and ERCP examinations were performed to confirm he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4acf280b1d29924495792d591755df2f
https://doi.org/10.1016/j.ijscr.2020.11.015

Zobrazit plný text záznamu

Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosis

Publikováno v: Hepatology research : the official journal of the Japan Society of HepatologyReferences. 50(11)

AIM Combination therapy with sofosbuvir (SOF) plus velpatasvir (VEL) is approved for patients with hepatitis C virus (HCV)-related decompensated cirrhosis. We analyzed the real-world efficacy of SOF/VEL therapy. METHODS Thirty-three patients with HCV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07bbc37e73b849ff4127d070ea3ca61
https://pubmed.ncbi.nlm.nih.gov/32914512

Zobrazit plný text záznamu

Plný text ve formátu HTML

Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non-alcoholic fatty liver disease and cardiovascular disease

Autor: Koji Arihiro, Kazuaki Chayama, Hiromi Kan, Tomokazu Ishitobi, Akira Hiramatsu, Hiroshi Aikata, Hideyuki Hyogo

Publikováno v: Hepatology Research. 45:533-539

Aim The main causes of mortality from non-alcoholic fatty liver disease (NAFLD) are cardiovascular disease (CVD) and malignancy. Eicosapentaenoic acid (EPA)/arachidonic acid (AA) ratio is known to be associated with CVD. However, a possible link betw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d58550a7bddd44561cf948d2bd70e92
https://doi.org/10.1111/hepr.12382

Zobrazit plný text záznamu

Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease

Autor: Tomokazu Ishitobi, Kazuaki Chayama, Sho-ichi Yamagishi, Hideyuki Hyogo, Yuki Kimura, Sayaka Maeda

Publikováno v: Clinical Biochemistry. 45:1554-1557

Pigment epithelium-derived factor (PEDF) is a glycoprotein that belongs to the superfamily of serine protease inhibitors with complex anti-oxidative, anti-fibrotic, and anti-inflammatory properties, thus being involved in cardiometabolic disorders. N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd28ace0dad0229cb3b9536647d9e92e
https://doi.org/10.1016/j.clinbiochem.2012.07.106

Zobrazit plný text záznamu

Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-alpha-lowering property

Autor: Kazuaki Chayama, Tomokazu Ishitobi, Hideyuki Hyogo, Yuki Kimura, Sho-ichi Yamagishi, Sayaka Maeda

Publikováno v: Digestive and Liver Disease. 44(6):492-496

Background: We have previously found that atorvastatin decreases liver injury markers in patients with nonalcoholic steatohepatitis. However, how atorvastatin treatment ameliorates the disease activity in nonalcoholic steatohepatitis patients remains

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343093eed0e1de5df69bb594b2995728
http://ir.lib.hiroshima-u.ac.jp/00034830

Zobrazit plný text záznamu

Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus

Autor: Kazuaki Chayama, Tomokazu Ishitobi, Koji Arihiro, Yuki Kimura, Hideyuki Hyogo, Yoshitaka Nabeshima

Publikováno v: Journal of Gastroenterology and Hepatology. 26:517-522

Background and Aim: Insulin resistance and diabetes mellitus (DM) are known to contribute to the progression of non-alcoholic fatty liver disease (NAFLD). However, the relationship between glucose metabolism and NAFLD is not well known. In this study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b46bfd94d13b134089fccb80635b8ced
https://doi.org/10.1111/j.1440-1746.2010.06567.x

Zobrazit plný text záznamu

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

Autor: Hideyuki Hyogo, Kazuaki Chayama, Yoshitaka Nabeshima, Motoki Inoue, Tomokazu Ishitobi, Michihiro Nonaka, Keiko Iwamoto, Susumu Tazuma, Koji Arihiro

Publikováno v: Metabolism. 57:1711-1718

Nonalcoholic steatohepatitis (NASH) is the hepatic manifestation of the metabolic syndrome. Currently, there is no established therapy for NASH. The aim of the present study was to evaluate the efficacy of atorvastatin in the treatment of NASH associ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::599ba16a69c02c2bc5205004e6179c0b
https://doi.org/10.1016/j.metabol.2008.07.030

Zobrazit plný text záznamu

Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis

Autor: Susumu Tazuma, Koji Arihiro, Masayoshi Takeuchi, Sho-ichi Yamagishi, Hideyuki Hyogo, Yoshitaka Nabeshima, Takashi Sato, Hidenori Ochi, Motoki Inoue, Kazuaki Chayama, Tomokazu Ishitobi, Michihiro Nonaka, Keiko Iwamoto

Publikováno v: Journal of Gastroenterology and Hepatology. 22:1112-1119

Background and Aim: Advanced glycation end products (AGE), senescent macroprotein derivatives formed at an accelerated rate in diabetes, play important roles in the pathogenesis of diabetic vascular complications. Recently, AGE have also been found t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f22d5e577f51f123c27d6f48371f35b5
https://doi.org/10.1111/j.1440-1746.2007.04943.x

Zobrazit plný text záznamu

A Nuclear Receptor-mediated Choleretic Action of Fibrates is Associated with Enhanced Canalicular Membrane Fluidity and Transporter Activity Mediating Bile Acid-independent Bile Secretion

Autor: Keiko Iwamoto, Yoshitaka Nabeshima, Susumu Tazuma, Mami Ogi, Michihiro Nonaka, Tomokazu Ishitobi, Yoshihiro Numata, Tomoji Nishioka, Motoki Inoue, Atsushi Yamaguchi, Hideyuki Hyogo, Takeyoshi Ajima, Kazuaki Chayama, Toshiya Kobuke, Daisuke Komichi

Publikováno v: Journal of Atherosclerosis and Thrombosis. 12:211-217

Fibrates are commonly used lipid-lowering agents that act via PPARalpha, a member of the nuclear hormone receptor superfamily. The mechanism(s) of fibrate-induced changes in the hepatic canalicular membrane and bile lipids are still unknown. Therefor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb175b40e23155471fe3e6983d66ff1
https://doi.org/10.5551/jat.12.211

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání